Bupropion is Not Effective for Treating Insomnia
Bupropion (Wellbutrin) is not recommended for treating insomnia and may actually worsen sleep problems due to its stimulating effects that commonly cause insomnia as a side effect. 1, 2
Evidence Against Using Bupropion for Insomnia
- Bupropion is associated with insomnia as one of its most common side effects, along with nervousness 1
- Clinical trials of bupropion SR reported insomnia occurring significantly more frequently with bupropion than with placebo 2
- Insomnia is recognized as a common adverse event that may require dose reduction or management strategies when using bupropion 2
Recommended Treatments for Insomnia
First-Line Treatment:
- Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia 3
- CBT-I has been shown to be more effective than pharmacotherapy for chronic insomnia in the long term 3
- Brief Behavioral Treatment for Insomnia (BBT-I) focusing on behavioral components can also be effective 3
Pharmacological Options (if needed):
For patients unable or unwilling to receive CBT-I, the recommended sequence for medication trials is:
Short-intermediate acting benzodiazepine receptor agonists or ramelteon
Low-dose doxepin (3 or 6 mg)
Sedating antidepressants
Why Bupropion May Worsen Insomnia
- Bupropion's mechanism of action involves inhibition of dopamine and norepinephrine reuptake, which creates stimulating effects 1
- In a study examining trazodone for antidepressant-associated insomnia, patients were specifically included because they experienced insomnia while taking bupropion 4
- Higher baseline insomnia scores were associated with earlier onset of antidepressant response with bupropion, but this doesn't indicate improvement in insomnia symptoms 5
Important Considerations and Pitfalls
- Sleep hygiene education alone is not effective for treating chronic insomnia and should be used in combination with other therapies 3
- Over-the-counter antihistamines or herbal supplements (valerian, melatonin) are not recommended for chronic insomnia due to lack of efficacy and safety data 3
- Older medications including barbiturates, barbiturate-type drugs, and chloral hydrate are not recommended due to significant adverse effects 3
- When pharmacotherapy is utilized, it should be supplemented with behavioral and cognitive therapies when possible 3
- Long-term medication use should be accompanied by consistent follow-up, ongoing assessment of effectiveness, and monitoring for adverse effects 3
In conclusion, bupropion would be a counterproductive choice for treating insomnia given its stimulating properties and tendency to cause insomnia as a side effect. Patients with insomnia would be better served by evidence-based treatments like CBT-I or, if pharmacotherapy is necessary, medications specifically indicated for insomnia treatment.